Funding for this research was provided by:
Dong-A ST Co., Ltd.
the National R&D Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea (1720150)
The Ministry of Health and Welfare, Republic of Korea (HA17C0055)
Received: 7 October 2018
Accepted: 16 May 2019
First Online: 28 May 2019
Ethics approval and consent to participate
: The study was conducted in full accordance with the guidelines for Good Clinical Practice and the Declaration of Helsinki, and was approved by the institutional ethics committees of each hospital and the KCSG institutional review board. The ClinicalTrials.gov identifier number was NCT02263495. Written informed consent was obtained from each participant.
: Written informed consent for publication of their clinical details was obtained from the patient.
: The authors declare that they have no competing interests.